---
figid: PMC6473060__fimmu-10-00774-g0002
figtitle: Points of complement inhibition
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6473060
filename: fimmu-10-00774-g0002.jpg
figlink: /pmc/articles/PMC6473060/figure/F2/
number: F2
caption: Points of complement inhibition. Steps of the classical complement activation
  pathway and some inhibitors available for targeting these steps are shown. These
  points of therapeutic intervention may render synergistic antitumor activities in
  combination with anti-PD-1/PD-L1 therapies.
papertitle: Complementing the Cancer-Immunity Cycle.
reftext: Ruben Pio, et al. Front Immunol. 2019;10:774.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8468514
figid_alias: PMC6473060__F2
figtype: Figure
redirect_from: /figures/PMC6473060__F2
ndex: f0745ff8-df1f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6473060__fimmu-10-00774-g0002.html
  '@type': Dataset
  description: Points of complement inhibition. Steps of the classical complement
    activation pathway and some inhibitors available for targeting these steps are
    shown. These points of therapeutic intervention may render synergistic antitumor
    activities in combination with anti-PD-1/PD-L1 therapies.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - mtSSB
  - cl
  - ci
  - AP-1-2beta
  - Cir
  - ac
  - yip7
  - mAcon1
  - C5
  - C5AR1
  - C3AR1
  - C3
  - ERVK-2
  - C1QA
  - C1QB
  - C1QC
  - C1R
  - C1S
  - SERPING1
  - CISH
  - KCNJ5
  - CIR1
  - VIM2P
  - C4B
  - C6
  - C7
  - C8A
  - C8B
  - C8G
  - C9
  - IONIS-FB
  - ACH-0144471
  - MoAb
  - ABP959
  - SKY59
  - Cl
  - SB290157
  - C1-INH
---
